Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diagnostic Agent Adverse Reaction”

62 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 62 results

Very early researchStudy completedNCT05775601
What this trial is testing

18F-LY3950321-01 Biodistribution and Safety Study

Who this might be right for
Diagnostic Agent Adverse ReactionRadiation Exposure
Avid Radiopharmaceuticals 6
Not applicableUnknownNCT06167564
What this trial is testing

Allergy Diagnostic Test Based on Microchip Technology

Who this might be right for
AllergyAllergy;FoodAllergy Pollen+1 more
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus 400
Large-scale testing (Phase 3)UnknownNCT03779347
What this trial is testing

Schistosomiasis Diagnosis Using a CAA Antigen Test

Who this might be right for
Schistosomiasis HematobiumDiagnosticDrug Reaction+1 more
Centre de Recherche Médicale de Lambaréné 100
Early research (Phase 1)WithdrawnNCT02921373
What this trial is testing

Tracking Peripheral Blood Mononuclear Cells With Fluorine MRI

Who this might be right for
Adverse Reaction to Diagnostic Agents and Kits Nos
Gregory A. Dekaban
Post-approval studies (Phase 4)UnknownNCT04962152
What this trial is testing

Naldebain and Video-assisted Thoracoscopic Surgery

Who this might be right for
AnalgesiaNausea and Vomiting, PostoperativeItching+2 more
Kaohsiung Medical University Chung-Ho Memorial Hospital 60
Not applicableStudy completedNCT06093815
What this trial is testing

Prospective Study to Assess Tissue Responses After Injection With Biostimulatory Products

Who this might be right for
Injection Site Reaction
Merz North America, Inc. 20
Not applicableStudy completedNCT07428915
What this trial is testing

Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists

Who this might be right for
Pustular Psoriasis (PP)Generalized Pustular Psoriasis (GPP)Eczema Atopic Dermatitis+11 more
AI Labs Group S.L 15
Not applicableUnknownNCT04302506
What this trial is testing

Correlative Cohort Study on the Clinical Features and Prognosis of Drug-induced Liver Injury

Who this might be right for
Drug-induced Liver Injury
Beijing Ditan Hospital 600
Not applicableStudy completedNCT00577798
What this trial is testing

Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin

Who this might be right for
Cardiac ToxicityChemotherapeutic Agent ToxicityLymphoma
University of Nebraska 10
Large-scale testing (Phase 3)Study completedNCT00716976
What this trial is testing

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Who this might be right for
Brain TumorCentral Nervous System TumorChildhood Germ Cell Tumor+6 more
Children's Oncology Group 131
Not applicableStudy completedNCT03581604
What this trial is testing

De-labeling of Patients With False Diagnosis of Penicillin Allergy

Who this might be right for
Allergy Drug
Oslo University Hospital 155
Not applicableStudy completedNCT05091931
What this trial is testing

Diagnosis, Antibiotic Prescribing Practices and Outcomes of cUTI in an Outpatient Setting

Who this might be right for
Urinary Tract Infections
Pathnostics 3,308
Large-scale testing (Phase 3)Study completedNCT00003937
What this trial is testing

Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma

Who this might be right for
Cardiac ToxicitySarcoma
Children's Oncology Group 253
Early research (Phase 1)Study completedNCT00003268
What this trial is testing

Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemia
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Testing effectiveness (Phase 2)UnknownNCT04351308
What this trial is testing

Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma

Who this might be right for
OsteosarcomaSurvivalChemotherapy Effect+1 more
Peking University People's Hospital 60
Not applicableLooking for participantsNCT06490029
What this trial is testing

Diagnostic of Various Ototoxicity Induced by Cancer Treatment

Who this might be right for
Ototoxicity, Drug-Induced
Direction Centrale du Service de Santé des Armées 540
Post-approval studies (Phase 4)Study completedNCT00199745
What this trial is testing

Differences in Atorvastatin Metabolite Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity

Who this might be right for
Muscular Diseases
Oslo University Hospital 53
Not applicableUnknownNCT04555642
What this trial is testing

Early Diagnosis of Therapy-associated Cardiotoxicity Basing on Multi-tracer Multimodality PET/MRI

Who this might be right for
Positron-Emission TomographyMagnetic Resonance Imaging
Peking University Cancer Hospital & Institute 120
Not applicableStudy completedNCT02162173
What this trial is testing

Dual Focus NBI and pCLE in FAP Related Duodenal Adenoma

Who this might be right for
Complication of Diagnostic ProcedureAdverse Effect of Diagnostic Agents, Subsequent Encounter
King Chulalongkorn Memorial Hospital 26
Early research (Phase 1)Study completedNCT00365781
What this trial is testing

Examination of Dermatologic Effects From Subcutaneous Injections of ISIS 113715

Who this might be right for
Type 2 Diabetes Mellitus
Ionis Pharmaceuticals, Inc. 10
Load More Results